Patents by Inventor Tihui Fu

Tihui Fu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination Immunotherapy For The Treatment of Cancer
    Publication number: 20220162315
    Abstract: Agonists to ICOS in combination with a blocking agent to a T cell inhibitory receptor (e.g., CTLA-4, PD-1, etc.) are demonstrated herein to be useful for the treatment of tumors.
    Type: Application
    Filed: September 14, 2021
    Publication date: May 26, 2022
    Inventors: James Allison, Padmanee Sharma, Sergio A. Quezada, Tihui Fu
  • Combination Immunotherapy For The Treatment of Cancer
    Publication number: 20190352398
    Abstract: Agonists to ICOS in combination with a blocking agent to a T cell inhibitory receptor (e.g., CTLA-4, PD-1, etc.) are demonstrated herein to be useful for the treatment of tumors.
    Type: Application
    Filed: December 10, 2018
    Publication date: November 21, 2019
    Inventors: James Allison, Padmanee Sharma, Sergio A. Quezada, Tihui Fu
  • Combination immunotherapy for the treatment of cancer
    Patent number: 10167337
    Abstract: Agonists to ICOS in combination with a blocking agent to a T cell inhibitory receptor (e.g., CTLA-4, PD-1, etc.) are demonstrated herein to be useful for the treatment of tumors.
    Type: Grant
    Filed: May 4, 2018
    Date of Patent: January 1, 2019
    Assignees: MEMORIAL SLOAN-KETTERING CANCER CENTER, BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: James Allison, Padmanee Sharma, Sergio A. Quezada, Tihui Fu
  • Combination Immunotherapy For The Treatment of Cancer
    Publication number: 20180251555
    Abstract: Agonists to ICOS in combination with a blocking agent to a T cell inhibitory receptor (e.g., CTLA-4, PD-1, etc.) are demonstrated herein to be useful for the treatment of tumors.
    Type: Application
    Filed: May 4, 2018
    Publication date: September 6, 2018
    Inventors: James Allison, Padmanee Sharma, Sergio A. Quezada, Tihui Fu
  • Combination immunotherapy for the treatment of cancer
    Patent number: 10023637
    Abstract: Agonists to ICOS in combination with a blocking agent to a T cell inhibitory receptor (e.g., CTLA-4, PD-1, etc.) are demonstrated herein to be useful for the treatment of tumors.
    Type: Grant
    Filed: May 3, 2016
    Date of Patent: July 17, 2018
    Assignees: Board of Regents, The University of Texas System, Memorial Sloan-Kettering Cancer Center
    Inventors: James Allison, Padmanee Sharma, Sergio A. Quezada, Tihui Fu
  • Combination Immunotherapy for the Treatment of Cancer
    Publication number: 20160244524
    Abstract: Agonists to ICOS in combination with a blocking agent to a T cell inhibitory receptor (e.g., CTLA-4, PD-1, etc.) are demonstrated herein to be useful for the treatment of tumors.
    Type: Application
    Filed: May 3, 2016
    Publication date: August 25, 2016
    Inventors: James Allison, Padmanee Sharma, Sergio A. Quezada, Tihui Fu
  • Combination immunotherapy for the treatment of cancer
    Patent number: 9375475
    Abstract: Agonists to ICOS in combination with a blocking agent to a T cell inhibitory receptor (e.g., CTLA-4, PD-1, etc.) are demonstrated herein to be useful for the treatment of tumors.
    Type: Grant
    Filed: April 10, 2014
    Date of Patent: June 28, 2016
    Assignees: Board of Regents, The University of Texas System, Memorial Sloan-Kettering Cancer Center
    Inventors: James Allison, Padmanee Sharma, Sergio A. Quezada, Tihui Fu
  • Combination Immunotherapy for the Treatment of Cancer
    Publication number: 20140308299
    Abstract: Agonists to ICOS in combination with a blocking agent to a T cell inhibitory receptor (e.g., CTLA-4, PD-1, etc.) are demonstrated herein to be useful for the treatment of tumors.
    Type: Application
    Filed: April 10, 2014
    Publication date: October 16, 2014
    Inventors: James Allison, Padmanee Sharma, Sergio A. Quezada, Tihui Fu
  • Combination immunotherapy for the treatment of cancer
    Patent number: 8709417
    Abstract: Agonists to ICOS in combination with a blocking agent to a T cell inhibitory receptor (e.g., CTLA-4, PD-I, etc.) are demonstrated herein to be useful for the treatment of tumors.
    Type: Grant
    Filed: September 30, 2010
    Date of Patent: April 29, 2014
    Assignees: Memorial Sloan-Kettering Cancer Center, Board of Regents
    Inventors: James Allison, Padmanee Sharma, Sergio A. Quezada, Tihui Fu
  • Combination Immunotherapy for the Treatment of Cancer
    Publication number: 20120251556
    Abstract: Agonists to ICOS in combination with a blocking agent to a T cell inhibitory receptor (e.g., CTLA-4, PD-I, etc.) are demonstrated herein to be useful for the treatment of tumors.
    Type: Application
    Filed: September 30, 2010
    Publication date: October 4, 2012
    Applicants: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM, MEMORIAL SLOAN-KETTERING CANCER CENTER
    Inventors: James Allison, Padmanee Sharma, Sergio A. Quezada, Tihui Fu